Product Name | MF | CAS | Details |
---|
1-Benzoylpyrrolidine-2-carboxylic acid | C12H13NO3 | 195719-48-3 | Details |
5-Chloro-2-methoxy-4-methylpyridine | C7H8ClNO | 851607-29-9 | Details |
Cadmium perchlorate hydrate | CdClH3O5 | 79490-00-9 | Details |
(6-(Benzyloxy)naphthalen-2-yl)boronic acid | C17H15BO3 | 152915-83-8 | Details |
Magnesium phosphate hydrate,99.00% | H2Mg3O9P2 | 53408-95-0 | Details |
Photobiotin (acetate) | C25H39N9O6S | 96087-38-6 | Details |
(2-Bromo-4,6-difluorophenyl)boronic acid | C6H4BBrF2O2 | 1315339-48-0 | Details |
(4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid | C13H11BCl2O3 | 1003298-85-8 | Details |
6-Phenylmethoxypyridine-3-carboxylic acid | C13H11NO3 | 94084-76-1 | Details |
5-Bromo-N-cyclohexylpyridine-2-carboxamide | C12H15BrN2O | 951885-08-8 | Details |
(5-Formyl-2-methylphenyl)boronic acid | C8H9BO3 | 1186398-35-5 | Details |
5-Fluoro-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | C14H17BFNO2 | 1192023-08-7 | Details |
2-Nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | C13H16BNO5 | 1268163-62-7 | Details |
1-Bromo-4,4-dimethylcyclohex-1-ene | C8H13Br | 1020253-13-7 | Details |
2-chlorosuccinic acid (Tofacitinib Impurity) | C4H5ClO4 | 16045-92-4 | Details |
5-(2-ethoxy-5-(piperazine-1-carbonothioyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-thione (Sildenafil Impurity) | C22H28N6OS2 | 1610830-81-3 | Details |
sodium (3R,5S)-5-(3-(2-cyclopropyl-4-(4-fluorophenyl)-1-oxidoquinolin-3-yl)oxiran-2-yl)-3,5-dihydroxypentanoate (Pitavastatin Impurity) | C25H24FNO6 | 1980814-90-1 | Details |
2-Amino-2-(4-heptylphenethyl)propane-1,3-diol (Fingolimod Impurity) | C18H31NO2 | 745767-97-9 | Details |
(3-((Methylamino)methyl)phenyl)boronic acid | C8H12BNO2 | 1146614-39-2 | Details |
6-Bromo-2-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C11H14BBrClNO2 | 1247726-85-7 | Details |
Oxane-2-carbaldehyde | C6H10O2 | 19611-45-1 | Details |
3-Benzoyl-7-methoxy-2h-chromen-2-one | C17H12O4 | 64267-12-5 | Details |
(1S,2S,3R,5S)-3-(7-Chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (Ticagrelor Impurity) | C14H20ClN5O4S | 2248538-63-6 | Details |
(4-(Thiazolidine-3-carbonyl)phenyl)boronic acid | C10H12BNO3S | 850589-33-2 | Details |
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide (Trelagliptin Impurity) | C40H42F2N10O6 | 2087874-94-8 | Details |
5-methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole (Tenofovir Impurity) | C18H23N6O5P | 1234081-04-9 | Details |
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide (Cabozantinib Impurity) | C28H24FN3O6 | 1628530-38-0 | Details |
4-Chloro-4'-methoxy-1,1'-biphenyl | C13H11ClO | 58970-19-7 | Details |
3,3-Difluorocyclopentan-1-amine | C5H9F2N | 939525-61-8 | Details |
3-Bromo-5-chloro-4-methoxybenzaldehyde | C8H6BrClO2 | 161565-36-2 | Details |
2-Morpholinoethyl methacrylate(stabilizedwithMEHQ) | C10H17NO3 | 2997-88-8 | Details |
Methyl 2,3-difluoro-4-methylbenzoate | C9H8F2O2 | 773874-06-9 | Details |
3-Bromo-5-(2-methoxyethoxy)pyridine | C8H10BrNO2 | 181585-07-9 | Details |
4-((R)-3-aminopiperidin-1-yl)-2-((6-((R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile (Trelagliptin Impurity) | C23H31N7O2 | 1917324-14-1 | Details |
((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol (Paroxetine Impurity) | C13H18FNO | 100332-12-5 | Details |
5-Chloro-2,3-dihydro-1H-indene-1-carboxylic acid | C10H9ClO2 | 66041-26-7 | Details |
(3-(Tert-butoxymethyl)phenyl)boronic acid | C11H17BO3 | 858364-78-0 | Details |
1-Bromo-3-chloro-2-iodo-5-(trifluoromethyl)benzene | C7H2BrClF3I | 175205-55-7 | Details |
(4-(Benzyloxy)-3-chloro-5-methoxyphenyl)boronic acid | C14H14BClO4 | 1218790-59-0 | Details |
sodium (2S,5S)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate (Avibactam Impurity) | C7H12N3NaO6S | 2064219-26-5 | Details |
2,3-Dibromopropan-1-amine hydrobromide | C3H8Br3N | 6963-32-2 | Details |
2-(Diisopropylamino)ethyl methacrylate(stabilizedwithMEHQ) | C12H23NO2 | 16715-83-6 | Details |
4-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | C13H15BN2O4 | 1218791-28-6 | Details |
4,4,5,5-Tetramethyl-2-(3-methyl-5-propoxyphenyl)-1,3,2-dioxaborolane | C16H25BO3 | 1218789-73-1 | Details |
(5,6,7,8-Tetrahydronaphthalen-1-yl)boronic acid | C10H13BO2 | 371765-41-2 | Details |
1-tert-Butyl 3-ethyl (3r,4s)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride | C12H23ClN2O4 | 1262849-90-0 | Details |
(S)-(S)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate (Solifenacin Impurity) | C23H26N2O2 | 732228-02-3 | Details |
N-methyl-4-(4-nitrophenoxy)picolinamide (Sorafenib Impurity) | C13H11N3O4 | 864272-34-4 | Details |
(4-(N-Butyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid | C18H24BNO5S | 913835-97-9 | Details |
(3,6-Dibromo-2-fluorophenyl)boronic acid | C6H4BBr2FO2 | 870778-92-0 | Details |
bis(5-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzo[d][1,3]dioxol-4-yl)methane (Paroxetine Impurity) | C39H40F2N2O6 | 1292846-10-6 | Details |
6-(4-((4-carboxybutyl)amino)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid (Apixaban Impurity) | C25H26N4O6 | 2264018-89-3 | Details |
2-(2-Vinylphenyl)-1,3,2-dioxaborinane | C11H13BO2 | 850567-61-2 | Details |
4-Hydroxydibenzothiophene | C12H8OS | 24444-75-5 | Details |
Methyl 3-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | C14H18BNO6 | 957065-97-3 | Details |
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (Abiraterone Impurity) | C24H31NO | 165334-72-5 | Details |
(4-((Methylsulfonyl)oxy)phenyl)boronic acid | C7H9BO5S | 957035-04-0 | Details |
2-(1-(4-Chlorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C14H18BClO2 | 850567-54-3 | Details |
9-(2-bromopropyl)-9H-purin-6-amine (Tenofovir Impurity) | C8H10BrN5 | 1884329-63-8 | Details |
(4-Propionylphenyl)boronic acid | C9H11BO3 | 186498-36-2 | Details |
(2-Bromo-6-fluoro-3-methylphenyl)methanol | C8H8BrFO | 1375069-06-9 | Details |
4,6-dichloro-N,N-dimethyl-1,3,5-triazin-2-amine (Vildagliptin Impurity) | C5H6Cl2N4 | 2401-64-1 | Details |
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one | C15H21BO3 | 1256359-22-4 | Details |
tert-Butyl (R)-3-(2-hydroxyethyl)piperidine-1-carboxylate | C12H23NO3 | 389889-62-7 | Details |
(3-Methyl-5-(trifluoromethyl)phenyl)boronic acid | C8H8BF3O2 | 850411-13-1 | Details |
(3-(Cyclopropylmethoxy)-5-methylphenyl)boronic acid | C11H15BO3 | 1256345-78-4 | Details |
(4-(Ethylsulfinyl)phenyl)boronic acid | C8H11BO3S | 863248-21-9 | Details |
(3-Chloro-4-ethoxyphenyl)methanol | C9H11ClO2 | 915922-38-2 | Details |
(4-(n-(2-Hydroxyethyl)sulfamoyl)phenyl)boronic acid | C8H12BNO5S | 850568-77-3 | Details |
2-(Bromomethyl)-2-phenyl-1,3-dioxolane | C10H11BrO2 | 3418-21-1 | Details |
1-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | C15H20BNO2 | 596819-10-2 | Details |
(R)-3-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl acrylate (Ibrutinib Impurity) | C28H28N6O4 | 2244619-11-0 | Details |
2-(Quinolin-8-yl)acetic acid | C11H9NO2 | 152150-04-4 | Details |
((2R,3R,4R)-3-(Benzoyloxy)-4-fluoro-5-hydroxy-4-methyltetrahydrofuran-2-yl)methyl benzoate (Sofosbuvir Impurity) | C20H19FO6 | 1884385-12-9 | Details |
2-Acetamido-2-methylpropanoic acid | C6H11NO3 | 5362-00-5 | Details |
N-(3,4-dichlorophenyl)-7-methoxy-6- (3-morpholinopropoxy)quinazolin-4- amine (Gefitinib Impurity) | C22H24Cl2N4O3 | 2089650-13-3 | Details |
4-(2-Methoxyphenyl)butanoic acid | C11H14O3 | 33209-75-5 | Details |
4-(Furan-2-yl)benzaldehyde | C11H8O2 | 60456-77-1 | Details |
1-(2-Fluorophenyl)cyclobutane-1-carbonitrile | C11H10FN | 28049-63-0 | Details |
3-Methoxycyclohex-1-ene | C7H12O | 2699-13-0 | Details |
3-Bromo-5-cyclopropyl-1,2-oxazole | C6H6BrNO | 1187933-05-6 | Details |
N-Ethyl-3-methoxyaniline | C9H13NO | 41115-30-4 | Details |
2-Chloro-4-iodo-6-methoxypyridine | C6H5ClINO | 1227602-76-7 | Details |
5-Nitro-2-(piperidin-1-yl)pyridine | C10H13N3O2 | 26820-61-1 | Details |
1-(3-Methylpyridin-2-yl)ethan-1-amine | C8H12N2 | 780803-63-6 | Details |
6-Bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine | C6H2BrClN2S | 1196151-70-8 | Details |
3-Methyl-1,2,4-oxadiazol-5-amine | C3H5N3O | 3663-39-6 | Details |
1-(Benzyloxy)-2-(chloromethyl)benzene | C14H13ClO | 23915-08-4 | Details |
5,8-Bis(5-bromo-4-(2-octyldodecyl)thiophen-2-yl)dithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole | C58H86Br2N2S5 | 1639449-99-2 | Details |
4-[4-(pyrimidin-2-yl)piperazin-1-yl]butan-1-ol | C12H20N4O | 223461-35-6 | Details |
6-Methyl-2-phenyl-1,4-dihydropyrimidin-4-one | C11H10N2O | 13514-79-9 | Details |
6-Chloro-5-fluoro-1h-1,3-benzodiazol-2-amine | C7H5ClFN3 | 142356-64-7 | Details |
(4-Methoxy-3-methylpyridin-2-yl)methyl acetate | C10H13NO3 | 102625-98-9 | Details |
4-Iodo-1-(oxetan-3-yl)-1h-pyrazole | C6H7IN2O | 1314393-99-1 | Details |
2-Bromo-n,n-diethylacetamide | C6H12BrNO | 2430-01-5 | Details |
1-Nitro-4-(prop-2-yn-1-yloxy)benzene | C9H7NO3 | 17061-85-7 | Details |
tert-Butyl 3-phenyl-1,4-diazepane-1-carboxylate | C16H24N2O2 | 1211596-44-9 | Details |
1-(4-Methyl-1h-imidazol-2-yl)ethan-1-one | C6H8N2O | 2524-90-5 | Details |
Product Total: Product Page: | ||||
91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 |